Research Overview
Concern over Workers Safety a Major Market Driver in Healthcare
Institutions
With over a million needlestick injuries - which occur while recapping
needles or transferring body fluids between containers - being reported in
Europe each year, the safety of clinical staff has become a major concern. Since
more than 20 pathogens - including human immunodeficiency virus (HIV) and
hepatitis - are transmitted through contaminated needles, there should be an
intensified demand for safety syringes. The concern of hospitals with respect to
employee wellbeing as well as potential litigation costs are further propelling
the market. The Needlestick Safety and Prevention Act in the United States
mandating the use of safety devices in healthcare settings has provided an
impetus to the demands for safer working conditions in Europe.
Frost & Sullivans recent strategic analysis on the safety syringes
market in Europe offers a comprehensive overview of market drivers, restraints
and industry trends. The research provides in-depth information to enable
participants to effectively identify and capitalise on the opportunities for
growth.
Safety Devices Industry Suffers a Setback due to Lack of Legislative
Support
Despite technological innovations, the market for safety syringes in Europe
is challenged by the lack of legislation pertaining to regulations for employee
safety. Laws aimed at improving the standards of safety in healthcare
institutions are anticipated to act as an effective market driver. Certain
countries such as Germany have issued directives that leave the decision
regarding use of safety syringes to the discretion of the purchasing agency.
"To overcome the challenge of lack of government support, participants
have to work toward educating end users on safety issues and the risks that
healthcare workers are exposed to daily," says the analyst of this
research. "Participants, assisted by advocacy groups, should ensure
adequate lobbying for government legislation that mandates the use of safety
products."
High Cost of Safety Syringes Affects Sales
In spite of the significant and proven advantages of safety syringes over the
ordinary ones, they have not made much progress in the end-user markets. A major
hindrance to growth is the high price of these devices. Cost of new technology
in an emerging market, combined with smaller target markets, keep prices
hovering towards the higher end of the price range and inhibit market expansion.
Frost & Sullivan Growth Partnership Service
Based on extensive and in-depth research, real-world consulting work, and new
theories tested in hundreds of companies across many industries, Frost &
Sullivan has evolved its Growth Partnership Services (GPS) programme that
provides established and emerging firms with powerful growth visions. Moving
beyond token mission statements, GPS provides an actionable vision to growth
consulting partners by illustrating how key intelligence and strategic research
based on defined goals can guide day-to-day behaviour and overall company
direction. The foundation of Frost & Sullivans GPS includes:
- Assisting companies to reach their full potential in the core business
- Providing growth strategies to help companies expand into related
businesses
- Preemptively redefining the core business during market turbulence
- Applying the Frost & Sullivan framework to identify and address common
mistakes resulting from misaligned corporate strategies
- Recommending growth management strategies through continuous partnership
To maximise the potential for growth within a firms internal and external
environment, Frost & Sullivan consultants can facilitate the creation of
strategic programmes that deliver improved market success. Frost &
Sullivans strengths lie in combining strategic understanding with market
expertise and applying these with absolute commitment to its clients growth.
View Cart
